Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes
Overview
Authors
Affiliations
Prevalence and timing of prenatal ultrasound findings in cytomegalovirus-infected pregnancies.
Van den Eede E, De Keersmaecker B, Lagrou K, Van der Veeken L, Vanwinkel S, Vangoitsenhoven M Acta Obstet Gynecol Scand. 2024; 104(2):302-308.
PMID: 39618174 PMC: 11782058. DOI: 10.1111/aogs.15018.
Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).
Schleiss M, Crooks C, Karthigeyan K, Kruc R, Otero C, Wang H Vaccines (Basel). 2024; 12(11).
PMID: 39591134 PMC: 11598149. DOI: 10.3390/vaccines12111231.
Pesch M, Schleiss M, Plotkin S, Permar S, Gautam R Vaccines (Basel). 2024; 12(11).
PMID: 39591129 PMC: 11598857. DOI: 10.3390/vaccines12111226.
Progress and Challenges in the Management of Congenital Cytomegalovirus Infection.
Szulc W, Szydlowska N, Smyk J, Majewska A Clin Pract. 2024; 14(6):2445-2462.
PMID: 39585019 PMC: 11587044. DOI: 10.3390/clinpract14060191.
Inhibition of human cytomegalovirus entry into mucosal epithelial cells.
He L, Hertel L, James C, Morgan I, Klingelhutz A, Fu T Antiviral Res. 2024; 230:105971.
PMID: 39074588 PMC: 11408113. DOI: 10.1016/j.antiviral.2024.105971.